• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Micrometastasis in non-small-cell lung cancer: Detection and staging.非小细胞肺癌的微转移:检测与分期。
Ann Thorac Med. 2012 Jul;7(3):149-52. doi: 10.4103/1817-1737.98848.
2
[Clinical study on the bone marrow micrometastases in patients with non-small cell lung cancer by immunohistochemical techniques].免疫组化技术检测非小细胞肺癌患者骨髓微转移的临床研究
Zhongguo Fei Ai Za Zhi. 2002 Oct 20;5(5):341-4. doi: 10.3779/j.issn.1009-3419.2002.05.06.
3
Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer.髂嵴活检与肋骨节段切除用于检测肺癌和食管癌骨髓中分离出的肿瘤细胞的比较
Eur J Cardiothorac Surg. 2001 May;19(5):576-9. doi: 10.1016/s1010-7940(01)00652-2.
4
Prognostic value of bone marrow micrometastasis in patients with operable esophageal squamous cell carcinoma: a long-term follow-up study.可手术食管鳞癌患者骨髓微转移的预后价值:一项长期随访研究。
J Thorac Oncol. 2014 Aug;9(8):1207-13. doi: 10.1097/JTO.0000000000000233.
5
Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.骨髓微转移与淋巴结阴性非小细胞肺癌手术患者的疾病复发和不良生存均相关:一项荟萃分析。
Interact Cardiovasc Thorac Surg. 2015 Jul;21(1):21-7. doi: 10.1093/icvts/ivv082. Epub 2015 Apr 15.
6
Bone marrow micrometastasis detected by RT-PCR in esophageal squamous cell carcinoma.通过逆转录聚合酶链反应检测食管鳞状细胞癌中的骨髓微转移
Oncol Rep. 2003 Nov-Dec;10(6):1879-83. doi: 10.3892/or.10.6.1879.
7
Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.早期前哨淋巴结阴性乳腺癌患者骨髓微转移不影响无病生存和总生存。
Ann Surg Oncol. 2014 Feb;21(2):401-7. doi: 10.1245/s10434-013-3315-9. Epub 2013 Oct 22.
8
Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma.非小细胞肺癌骨髓微转移的临床意义
Cancer. 2004 Feb 15;100(4):794-800. doi: 10.1002/cncr.20027.
9
Bone marrow micrometastases in patients with stage I-II localised prostate cancer.I-II期局限性前列腺癌患者的骨髓微转移
Eur J Cancer. 2001 Oct;37(15):1847-52. doi: 10.1016/s0959-8049(01)00212-x.
10
Occult micrometastasis to bone marrow in early lung cancer: a clinicopathologic study from West Bengal, India.
Asian Pac J Cancer Prev. 2010;11(3):747-51.

引用本文的文献

1
Perioperative Management of Non-Small Cell Lung Cancer in the Era of Immunotherapy.免疫治疗时代非小细胞肺癌的围手术期管理
Cells. 2025 Jun 25;14(13):971. doi: 10.3390/cells14130971.
2
Heart myxoma develops oncogenic and metastatic phenotype.心脏黏液瘤会发展出致癌和转移的表型。
J Cancer Res Clin Oncol. 2019 May;145(5):1283-1295. doi: 10.1007/s00432-019-02897-0. Epub 2019 Mar 21.
3
The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.肿瘤的临床病理特征对结直肠癌患者肝微转移检测的意义。
J Res Med Sci. 2014 May;19(5):410-3.
4
[The prognostic value of micrometastasis in non-small cell lung cancer].[微转移在非小细胞肺癌中的预后价值]
Zhongguo Fei Ai Za Zhi. 2013 Sep;16(9):492-8. doi: 10.3779/j.issn.1009-3419.2013.09.10.

本文引用的文献

1
Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.晚期非小细胞肺癌患者的骨髓微转移
Lung Cancer. 2008 Aug;61(2):170-6. doi: 10.1016/j.lungcan.2007.12.018. Epub 2008 Feb 7.
2
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.国际肺癌研究协会肺癌分期项目:关于在即将出版的(第七版)《恶性肿瘤TNM分类》中修订TNM分期分组的建议。
J Thorac Oncol. 2007 Aug;2(8):706-14. doi: 10.1097/JTO.0b013e31812f3c1a.
3
Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.基质金属蛋白酶-13表达与非小细胞肺癌的骨髓微浸润及预后相关。
Lung Cancer. 2006 Jun;52(3):349-57. doi: 10.1016/j.lungcan.2006.01.011. Epub 2006 Mar 29.
4
Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment.抑制微转移的维持治疗:辅助性癌症治疗的新挑战。
Clin Cancer Res. 2005 Aug 1;11(15):5337-41. doi: 10.1158/1078-0432.CCR-05-0437.
5
Insurgent micrometastases: sleeper cells and harboring the enemy.隐匿性微转移:潜伏细胞与暗藏的敌人
J Surg Oncol. 2005 Mar 15;89(4):207-10. doi: 10.1002/jso.20199.
6
Prognostic significance of micrometastasis in non-small-cell lung cancer.非小细胞肺癌微转移的预后意义
Clin Lung Cancer. 2004 Jan;5(4):214-25. doi: 10.3816/CLC.2004.n.002.
7
Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study.切除的非小细胞肺癌患者骨髓和淋巴结中细胞角蛋白阳性细胞的预后价值:一项多中心前瞻性研究
Ann Thorac Surg. 2003 Jul;76(1):194-201; discussion 202. doi: 10.1016/s0003-4975(03)00130-9.
8
Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed.乳腺癌患者骨髓中孤立肿瘤细胞的检测:髂前和髂后嵴穿刺的意义及分析的单核细胞数量
Cytotherapy. 2003;5(1):40-5. doi: 10.1080/14653240310000065.
9
Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.
Ann Thorac Surg. 2002 Jul;74(1):278-84. doi: 10.1016/s0003-4975(01)03376-8.
10
Bone marrow micrometastasis might not be a short-term predictor of survival in early stages non-small cell lung carcinoma.骨髓微转移可能不是早期非小细胞肺癌生存的短期预测指标。
Eur J Cardiothorac Surg. 2001 Sep;20(3):481-8. doi: 10.1016/s1010-7940(01)00830-2.

非小细胞肺癌的微转移:检测与分期。

Micrometastasis in non-small-cell lung cancer: Detection and staging.

机构信息

Department of Thoracic Surgery, Al Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Ann Thorac Med. 2012 Jul;7(3):149-52. doi: 10.4103/1817-1737.98848.

DOI:10.4103/1817-1737.98848
PMID:22924073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3425047/
Abstract

BACKGROUND

The clinical relevance of bone marrow micrometastasis (BMM) in non-small-cell lung cancer is undetermined, and the value of such analyses in advanced stage patients has not been clearly assessed previously. This study was conducted to estimate the accuracy of both polymerase chain reaction (PCR) and immunohistochemistry (IHC) in micrometastases detection and determine the best site for bone marrow biopsy in order to find micrometastasis.

METHODS

This prospective cross-sectional study was performed in the Department of Thoracic Surgery, Alzahra University Hospital from September 2008 to June 2009. To evaluate the bone marrow, a 3-cm rib segment and an aspirated specimen from the iliac bone prior to tumor resection were taken. PCR and IHC were performed for each specimen to find micrometastasis.

RESULTS

Of 41 patients, 14 (34%) were positive for BMM by PCR compared with two positive IHC (4.8%). All BMMs were diagnosed in rib segments, and iliac specimens were all free from metastatic lesion. Our data showed no significant association between variables such as age, sex, histology, tumor location, side of tumor, involved lobe, smoking, or weight loss and presence of BMM.

CONCLUSION

PCR could use as a promising method for BMM detection. BMM in a sanctuary site (rib) is not associated with advanced stages of lung cancer. In addition, when predictor variables such as age, sex, histology, tumor location, smoking, or weight loss are analyzed, no correlation can be found between micrometastasis prevalence and any of those variables.

摘要

背景

骨髓微转移(BMM)在非小细胞肺癌中的临床意义尚不确定,以前也没有明确评估此类分析在晚期患者中的价值。本研究旨在评估聚合酶链反应(PCR)和免疫组织化学(IHC)在微转移检测中的准确性,并确定进行骨髓活检的最佳部位以发现微转移。

方法

这是一项前瞻性的病例对照研究,于 2008 年 9 月至 2009 年 6 月在阿尔扎赫拉大学医院胸外科进行。为了评估骨髓,在肿瘤切除前从肋骨的 3cm 节段和髂骨中抽取骨髓抽吸标本。对每个标本进行 PCR 和 IHC 以寻找微转移。

结果

41 例患者中,14 例(34%)PCR 检测到 BMM,而 2 例 IHC 阳性(4.8%)。所有 BMM 均在肋骨段诊断,髂骨标本均无转移性病变。我们的数据显示,BMM 的存在与年龄、性别、组织学、肿瘤位置、肿瘤侧、受累肺叶、吸烟或体重减轻等变量之间没有显著相关性。

结论

PCR 可作为检测 BMM 的一种很有前途的方法。避难所部位(肋骨)的 BMM 与肺癌晚期无关。此外,当分析年龄、性别、组织学、肿瘤位置、吸烟或体重减轻等预测变量时,无法发现微转移发生率与这些变量中的任何一个之间存在相关性。